Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc. (RCKT): 25 pipeline candidates · ~9 mo cash runway · 13 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
9.4 months
D/E 0.20 · 3% dilution
N/A
25 candidates
N/A
1 buy · 14 sells (180d)
A transparent, data-derived signal for Rocket Pharmaceuticals Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$300.3M
Cash
$51.0M
Quarterly Burn
$45.4M
Runway
9.4 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (25 candidates)
Showing 10 of 25 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
196
Total value held
$350.5M
| Holder | Shares | Value |
|---|---|---|
| rtw investments, lp | 17,687,772 | $63.3M |
| blackrock, inc. | 7,834,795 | $28.0M |
| vanguard capital management llc | 7,551,472 | $27.0M |
| citigroup inc | 5,107,708 | $18.3M |
| vanguard portfolio management llc | 4,690,215 | $16.8M |
| state street corp | 4,485,989 | $16.1M |
| maverick capital ltd | 3,567,372 | $12.8M |
| newtyn management, llc | 3,165,900 | $11.3M |
| millennium management llc | 3,118,124 | $11.2M |
| aqr capital management llc | 3,069,930 | $11.0M |
Showing top 10 of 196 institutional holders of Rocket Pharmaceuticals Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Rocket Pharmaceuticals Inc.'s pipeline?
Rocket Pharmaceuticals Inc. (RCKT) has 25 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Rocket Pharmaceuticals Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Rocket Pharmaceuticals Inc. has approximately 9.4 months of cash runway.
What is Rocket Pharmaceuticals Inc.'s market capitalization?
Rocket Pharmaceuticals Inc.'s market capitalization is approximately $300.3M.
Who is the CEO of Rocket Pharmaceuticals Inc.?
Dr. Gaurav D. Shah M.D. is the chief executive officer of Rocket Pharmaceuticals Inc. (RCKT).
Get the full picture on Rocket Pharmaceuticals Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.